This inventor holds 2 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Mammoth Biosciences, Inc.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: The Innovations of Maria-Nefeli Tsaloglou in Nuclease Technology
Introduction
Maria-Nefeli Tsaloglou is an accomplished inventor based in San Francisco, CA, renowned for her contributions in the field of biotechnology. With a total of two patents to her name, Maria's innovative work focuses on programmable nuclease compositions and their application in detecting various diseases and genetic disorders. Her pioneering efforts are instrumental in advancing diagnostic methodologies.
Latest Patents
Maria-Nefeli Tsaloglou's latest patents encompass devices, systems, fluidic devices, and kits designed for the detection of target nucleic acids associated with a variety of health conditions, including diseases, cancers, and genetic disorders. These innovative tools utilize a combination of reagents, including a guide nucleic acid for targeting specific nucleic acids, a programmable nuclease, and a single-stranded detector nucleic acid equipped with a detection moiety. This technology not only identifies disease markers but also provides insights into genotypes, phenotypes, or ancestral origins.
Career Highlights
Maria is currently affiliated with Mammoth Biosciences, Inc., an organization known for its groundbreaking work in diagnostic technologies. Her role at the company involves developing cutting-edge solutions that leverage programmable nuclease technology, exemplifying her commitment to advancing medical sciences and improving patient outcomes.
Collaborations
Throughout her career, Maria has had the opportunity to work alongside talented individuals, including her coworkers Janice Sha Chen and Ashley Tehranchi. These collaborations foster an environment of creativity and innovation, allowing them to tackle complex challenges in the biotechnology sector together.
Conclusion
Maria-Nefeli Tsaloglou is a distinguished inventor whose contributions to programmable nuclease technology are shaping the future of disease detection and genetic analysis. Her work at Mammoth Biosciences, Inc., coupled with her collaborative spirit, positions her as a leading figure in the field of biotechnology, paving the way for significant advancements in medical diagnostics. Maria's journey exemplifies the impact that dedicated inventors can have on improving health outcomes worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile